We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Draws attention to twin problems that restrain learning and result in wide inequalities: home background and teaching quality
The government is seeking people to appoint to lists of arbitrators and expert panellists for the dispute settlement mechanisms within the UK-EU Trade and Cooperation Agreement (TCA).
Policies and measures to tackle unacceptable behaviour across Defence, including ways to respond and report it.
Product recall for Magnetic Bead Maze Monkey Toy presenting high risk of choking, injuries and asphyxiation.
Cygnus Pharma Ltd. Have informed MHRA that the European Article Number (EAN) barcode printed on various packs of Trazodone Hydrochloride 50mg/5ml Oral Solution, is defective and returns the incorrect information.
The MHRA has re-issued this notification as Class 3 recall based on further assessment. Please note the new actions for healthcare professionals listed within the notification. Doncaster Pharma Limited have identified an error relating to the Braille printed on the...
Help available and steps you should take if you have a medical emergency or are hospitalised abroad, including for planned treatment.
Understand how trading conditions and insurance can limit the financial risk for freight forwarders.
Explains control of advertisement regime.
Kent Pharma UK is recalling various batches of Itraconazole 10mg/ml Oral Solution as a precautionary measure due to out of specification in the appearance of the solution, particularly the presence of suspended particles or clusters of crystals.
This paper reviews literature on young people’s daily transport and mobility experiences and potential, with the aim of identifying research gaps
Manx Healthcare Ltd. has informed MHRA that they have identified a problem with the product packaging of the batch indicated in the table.
Viatris UK Healthcare Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in the specified batches of Oxcarbazepine 150 mg, 300 mg & 600 mg Film-Coated Tablets do not contain the most up to date safety information.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).